OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma
Yongwei Gu, Yue Du, Liangdi Jiang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications
Liwei Wang, Di Wang, Zhaoming Ye, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 62

Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
Qian Yang, Shisheng Li, Haibo Ou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 42

A comprehensive review of challenges and advances in exosome-based drug delivery systems
Sushesh Srivatsa Palakurthi, Brijesh Shah, Sumedha Kapre, et al.
Nanoscale Advances (2024)
Open Access | Times Cited: 18

Emerging role of exosomes in cancer therapy: progress and challenges
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 12

Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management
Laura Maria Gosman, Dana Antonia Țăpoi, Mariana Costache
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15881-15881
Open Access | Times Cited: 41

The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials
Yanlun Gu, Bingqi Dong, Xu He, et al.
Pharmacological Research (2023) Vol. 189, pp. 106694-106694
Open Access | Times Cited: 29

Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023
Sinan Ai, Yake Li, Hui Juan Zheng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10

Antitumor mechanisms and future clinical applications of the natural product triptolide
Shiwei Bao, Mei Yi, Bo Xiang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9

Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications
Ute Reuning, Vincenzo Maria D’Amore, Kairbaan Hodivala‐Dilke, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108193-108193
Closed Access | Times Cited: 1

Pharmacological, computational, and mechanistic insights into triptolide’s role in targeting drug-resistant cancers
Md Sadique Hussain, Somdutt Mujwar, M. Arockia Babu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1

Exosomal lncRNA-MIAT promotes neovascularization via the miR-133a-3p/MMP-X1 axis in diabetic retinopathy
Xinsheng Li, Qiuchen Cao, Changlin Xu, et al.
Experimental Eye Research (2024) Vol. 243, pp. 109912-109912
Closed Access | Times Cited: 6

Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy
Liuxiang Chu, Yuchen Sun, Yanyan Zhao, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124262-124262
Closed Access | Times Cited: 6

Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi‐Kenarsari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Extracellular Vesicles-Based Cell-Cell Communication in Melanoma: New Perspectives in Diagnostics and Therapy
Katarzyna Kluszczyńska, Małgorzata Czyż
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 965-965
Open Access | Times Cited: 14

Biology and function of exosomes in tumor immunotherapy
Can Liu, Cong Xia, Chenglai Xia
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115853-115853
Open Access | Times Cited: 14

Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications
Jessica N. Ziegler, Changhai Tian
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15206-15206
Open Access | Times Cited: 13

Engineering M2 type macrophage-derived exosomes for autoimmune hepatitis immunotherapy via loading siRIPK3
Lu Zhang, Man Liu, Qiu Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116161-116161
Open Access | Times Cited: 4

Smart Delivery Vehicles for Cancer: Categories, Unique Roles and Therapeutic Strategies
Yiyu Zeng, Yijun Gao, Liming He, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 17, pp. 4275-4308
Open Access | Times Cited: 4

The latest applications of exosome-mediated drug delivery in anticancer therapies
Zhiwei Wen, Wei Zhang, Wei Wu
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114500-114500
Closed Access

Extracellular Vesicle‐Based Antitumor Nanomedicines
Mingfeng Li, Yanfei Liu, Fei Liu, et al.
Advanced Healthcare Materials (2025)
Closed Access

Exosomes and solid cancer therapy: where are we now?
Tomáš Zemánek, Ľuboš Danišovič, Andreas Nicodemou
Medical Oncology (2025) Vol. 42, Iss. 3
Open Access

Ellipticine targets FGFR3 to mediate the RAS/MAPK-P38 signalling pathway to induce apoptosis in hepatocellular carcinoma cells
Deng Ling, Xiang Chen, Guolin Hu, et al.
3 Biotech (2025) Vol. 15, Iss. 5
Closed Access

Exosomes as natural vectors for therapeutic delivery of bioactive compounds in skin diseases
Somayeh Keshtkar, Zahra Asvar, Haniyeh Najafi, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

The therapeutic potential of natural products for treating pancreatic cancer
Xia He, Ning Wang, Yu Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top